Nkarta (NKTX) Capital Expenditures (2019 - 2026)

Nkarta's (NKTX) quarterly Capital Expenditures came in at $413000.0 in Q1 2026, down 20.27% year-on-year from $518000.0 in Q1 2025, and down 26.25% quarter-over-quarter from $560000.0 in Q4 2025.

Nkarta (NKTX) Capital Expenditures (2019 - 2026) Analysis & Trends

Nkarta's Capital Expenditures history runs 8 years deep, the most recent figure standing at $413000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 20.27% year-over-year to $413000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 76.79% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 72.6% from the prior year.
  • Capital Expenditures declined to $413000.0 in Q1 2026 per NKTX's latest filing, from $560000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $35.0 million in Q4 2022 and bottomed at -$8000.0 in Q3 2025.
  • The 5-year median for Capital Expenditures is $1.8 million (2022), against an average of $4.8 million.
  • Across the five-year window, Capital Expenditures soared 3105.67% in 2022 and sank 101.03% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at $35.0 million in 2022, then tumbled by 80.57% to $6.8 million in 2023, then plunged by 83.8% to $1.1 million in 2024, then tumbled by 49.23% to $560000.0 in 2025, then slipped by 26.25% to $413000.0 in 2026.
  • Per Business Quant, the three latest NKTX Capital Expenditures figures stand at $413000.0 (Q1 2026), $560000.0 (Q4 2025), and -$8000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Nkarta 170.79 Mn 170.79 Mn - 413,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 413,000.00
Mar 31, 2026 413,000.00
Dec 31, 2025 560,000.00
Dec 31, 2025 560,000.00
Sep 30, 2025 -8,000.00
Sep 30, 2025 -8,000.00
Jun 30, 2025 138,000.00
Jun 30, 2025 138,000.00
Mar 31, 2025 518,000.00
Mar 31, 2025 518,000.00
Dec 31, 2024 1.10 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 777,000.00
Sep 30, 2024 777,000.00
Jun 30, 2024 2.35 Mn
Jun 30, 2024 2.35 Mn
Mar 31, 2024 175,000.00
Mar 31, 2024 175,000.00
Dec 31, 2023 6.81 Mn
Dec 31, 2023 6.81 Mn